Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 6, 2009, Pages 577-586

  Kreuz, Sebastian ^a   Schoelch, Corinna ^a   Thomas, Leo ^a   Rist, Wolfgang ^a   Rippmann, Jörg F ^a   Neubauer, Heike ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

ACC1; ACC2; Quantitative RT PCR; Zucker fatty rat; Zucker rat

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE 1; ACETYL COENZYME A CARBOXYLASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; LIVER; MALE; MASS SPECTROMETRY; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; TISSUE DISTRIBUTION; ZUCKER DIABETIC FATTY RAT;

ACETYL-COA CARBOXYLASE; AGING; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS; DIET; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDICATOR DILUTION TECHNIQUES; ISOENZYMES; MALE; OBESITY; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PROTEOMICS; RATS; RATS, WISTAR; RATS, ZUCKER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIES SPECIFICITY; TANDEM MASS SPECTROMETRY; TRIGLYCERIDES;

EID: 70350590917     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.997     Document Type: Article

References (30)

1. Harwood HJ Jr. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition. Expert Opin Ther Targets 2005; 9: 267-281. (Pubitemid 40613868)
2. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999; 276: E1-E18. (Pubitemid 29065588)
3. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7-18.
4. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997; 244: 1-14. (Pubitemid 27079689)
5. Widmer J, Fassihi KS, Schlichter SC, et al. Identification of a second human acetyl-CoA carboxylase gene. Biochem J 1996; 316(Pt 3): 915-922. (Pubitemid 26280088)
6. Kim KH. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu Rev Nutr 1997; 17: 77-99.
7. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ. The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci U S A 2000; 97: 1444-1449.
8. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001; 291: 2613-2616. (Pubitemid 32249687)
9. Abu-Elheiga L, Oh W, Kordari P, Wakil SJ. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high- carbohydrate diets. Proc Natl Acad Sci U S A 2003; 100: 10 207-10 212. (Pubitemid 37071857)
10. Brownsey RW, Boone AN, Elliott JE, Kulpa JE, Lee WM. Regulation of acetyl-CoA carboxylase. Biochem Soc Trans 2006; 34: 223-227.
11. Wakil SJ, bu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 2009; 50: (Suppl.): S138-S143.
12. Ruderman N, Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 2004; 3: 340-351. (Pubitemid 38499761)
13. Prentki M, Corkey BE. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?. Diabetes 1996; 45: 273-283. (Pubitemid 26069039)
14. Saggerson D. Malonyl-CoA, a key signaling molecule in mammalian cells. Annu Rev Nutr 2008; 28: 253-272.
15. Liu YQ, Jetton TL, Leahy JL. Beta-cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic zucker fatty rats. J Biol Chem 2002; 277: 39 163-39 168.
16. Leonard BL, Watson RN, Loomes KM, Phillips ARJ, Cooper GJ. Insulin resistance in the Zucker diabetic fatty rat: A metabolic characterisation of obese and lean phenotypes. Acta Diabetol 2005; 42: 162-170.
17. Nolan CJ, Leahy JL, Delghingaro-Augusto V, et al. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia 2006; 49: 2120-2130. (Pubitemid 44168480)
18. Peterson RG, Shaw WN, Neel M, Little LA. Eichberg J Zucker diabetic fatty rat as a model for noninsulin-dependent diabetes mellitus. ILAR News 1990; 32(3): 16-19.
19. Kuhlmann J, Neumann-Haefelin C, Belz U, et al. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes 2003; 52: 138-144. (Pubitemid 36042118)
20. Etgen GJ, Oldham BA. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism 2000; 49: 684-688.
21. Harwood HJ Jr, Petras SF, Shelly LD, et al. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J Biol Chem 2003; 278: 37 099-37 111.
22. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003; 100: 6940-6945. (Pubitemid 36706372)
23. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006; 5: 573-588.
24. Bianchi A, Evans JL, Iverson AJ, Nordlund AC, Watts TD, Witters LA. Identification of an isozymic form of acetyl-CoA carboxylase. J Biol Chem 1990; 265: 1502-1509. (Pubitemid 20048973)
25. Iverson AJ, Bianchi A, Nordlund AC, Witters LA. Immunological analysis of acetyl-CoA carboxylase mass, tissue distribution and subunit composition. Biochem J 1990; 269: 365-371. (Pubitemid 20236026)
26. Nogalska A, Sucajtys-Szulc E, Swierczynski J. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism 2005; 54: 1041-1047. (Pubitemid 41033105)
27. Ide T, Nakazawa T, Mochizuki T, Murakami K. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats. Metabolism 2000; 49: 521-525. (Pubitemid 30196581)
28. Serkova NJ, Jackman M, Brown JL, et al. Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol 2006; 44: 956-962.
29. Mao J, DeMayo FJ, Li H, et al. Liver-specific deletion of acetyl- CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci U S A 2006; 103: 8552-8557. (Pubitemid 43838493)
30. Harada N, Oda Z, Hara Y, et al. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. Mol Cell Biol 2007; 27: 1881-1888. (Pubitemid 46310050)